C07C 317 - Sulfones; Sulfoxides

Patents for C07C 317 - Sulfones; Sulfoxides (15,874)
11/2004
11/25/2004	CA2524780A1 Compounds for treatment of inflammation, diabetes and related disorders
11/24/2004	EP1478621A2 Substituted aryl ketones
11/24/2004	EP1318976B1 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
11/24/2004	CN1549731A Stilbene derivatives and their use for binding and imaging amyloid plaques
11/24/2004	CN1176918C Intermediate of alpha-substituted benzene acetic acid derivate with farm pesticide activity
11/23/2004	US6822120 Sulfone liver X-receptor modulators
11/23/2004	US6821960 Glucagon antagonists/inverse agonists
11/18/2004	WO2004099128A1 Method for synthesizing metal complex
11/18/2004	WO2004099127A1 Novel compounds as kinase inhibitors
11/18/2004	WO2004099125A1 Method for crystallizing guanidinium salts
11/18/2004	WO2004098516A2 Cyclic derivatives as modulators of chemokine receptor activity
11/18/2004	US20040229959 for example, (E)-4-fluorostyryl-4-trifluoromethyl-benzylsulfone, (E)-2-trifluoromethyl-4-fluorostyryl-2,4-dichlorobenzyl-sulfone; for treatment of breast, prostate, ovarian, lung, colorectal, brain (i.e., glioma) and renal cancers
11/18/2004	US20040229955 Antibacterial agents
11/18/2004	US20040229949 New 3-aryl propionic acid derivatives and analogs
11/18/2004	US20040229946 Antidiabetic agents
11/18/2004	US20040229922 Sulfur compounds such as phenylmethyl [2R-hydroxy-3-[(3-methylbutyl) (phenylsulfonyl)amino]-1S-(phenylmethyl)propyl]carbamate, used for prevention of viral diseases and replication
11/18/2004	US20040229869 For prophylaxis and therapy of medical indications associated with estrogen dependent diseases or syndromes related to osteoporosis, bone loss, bone formation, cardiovascular disorders, neurodegenerative disorders, menopausal disorders, physiological disorders, diabetes disorders, prostatic carcinoma
11/18/2004	CA2524718A1 Method for crystallizing guanidinium salts
11/17/2004	EP1477477A1 Process for preparation of carotenoids
11/17/2004	EP1476423A2 Arylsulfonamidobenzylic compounds
11/17/2004	EP1289980B1 Bicyclyl or heterobicyclylmethanesulfonylamino-substituted n-hydroxyformamides
11/17/2004	CN1547570A Substituted c-cyclohexylmethylamine derivatives
11/17/2004	CN1546469A Method for producing sulfolane by hydrogenation of sulfolene
11/17/2004	CN1546462A Insecticidal antibacterial sulphur , oxygen and oxime-containing ether compounds
11/17/2004	CN1176068C Prepn of isobutene oxysulfide
11/17/2004	CN1176067C Anti-tumor 2-amino-carbonyl-1,2-di (methylsulfonyl)-1-(substituted) diazane
11/16/2004	US6818775 Treatment of skin-related diseases or prevention of certain undesired side effects of administered retinoids
11/16/2004	US6818766 Process for making bicalutamide and intermediates thereof
11/16/2004	US6818765 Benzene-sulphonamide derivatives and their uses
11/16/2004	US6818666 Bi-aromatic compounds linked via a heteroethylene radical, and pharmaceutical and cosmetic compositions using them
11/16/2004	CA2092306C Disubstituted aryl compounds exhibiting selective leukotriene b4 antagonist activity
11/11/2004	WO2004066963A3 N-cyclohexylaminocarbonyl benzenesulfonamide derivatives
11/10/2004	EP1474440A2 Coniosulphides and their derivatives, method for their production and use as medicaments
11/10/2004	EP1474381A1 Phenylalanine derivatives as herbicides
11/10/2004	EP0652868B1 INHIBITORS OF c-AMP PHOSPHODIESTERASE
11/10/2004	CN1545501A Novel cyclohexyl sulphones
11/09/2004	US6815556 Killing plant diseases
11/09/2004	US6815133 Comprising charge transport compound, charge generating compound, and electrically conductive substrate over which charge transport composition and charge generating compound are located
11/09/2004	CA2126195C Aromatic esters of phenylenedialkanoates as inhibitors of human neutrophil elastase
11/04/2004	WO2004094650A2 Synthesis of labeled metabolites
11/04/2004	WO2004094362A1 CaSR ANTAGONIST
11/04/2004	US20040220411 Oxalic acid derivatives
11/04/2004	US20040220241 Substituted biphenyl derivatives
11/04/2004	US20040220074 Compounds for a controlled release of active molecules
11/03/2004	EP1472576A2 Sulfonate derivatives and the use therof as latent acids
11/03/2004	EP1472214A2 Compounds for inhibiting insulin secretion and methods related thereto
11/03/2004	EP1445251A9 Aminoacetonitrile derivative, agricultural and horticultural insecticide containing the same, and use thereof
11/03/2004	EP1317425B1 Resorcinol derivatives
11/03/2004	EP1294677B1 Benzophenones and sulfones as inhibitors of glycine uptake
11/03/2004	CN1543452A 1,4-disubstituted benzenes as insecticides
11/03/2004	CN1173991C Fik-1 as receiptor of growth factor of blood vessel inner-skin
11/03/2004	CN1173933C Preparing D-(-)-Su's 1-R-substituted phenyl-2-difluoro acetoamino-3-fluoro-1-propanol from L type substituted phenyl serine ester
11/02/2004	US6812362 Amidation; efficiency, higher yields, performed at or near room temperature, energy savings
11/02/2004	US6812257 Polysubstituted indan-1-ol systems for the prophylaxis or treatment of obesity
11/02/2004	US6812256 Reducing weight in mammals; anorectic action
11/02/2004	US6812229 Carbamate derivative and agricultural/horticultural fungicide
10/2004
10/28/2004	WO2004092145A1 Alpha substituted carboxylic acid as ppar modulators
10/28/2004	WO2004004648A3 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
10/28/2004	US20040214930 Compounds such as S-substituted 4(3-mercapto/sulfinyl-2-hydroxypropylamino)diphenylamine as as stabilizers for elastomers
10/28/2004	US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis
10/28/2004	US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004	US20040214874 Inhibition of protein-tyrosine kinase cmet to block cancer cell proliferation, oral bioavailibility; 2-(2,6-dichlorophenyl)-4-phenyl-5-(pyrimidin-4yl)-1H-imidazoles
10/28/2004	CA2521915A1 Alpha substituted carboxylic acid as ppar modulators
10/27/2004	EP1471049A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
10/27/2004	EP1470102A1 Substituted methylene amide derivatives as modulators of protein tyrosine phosphatases (ptps)
10/27/2004	EP0968196B1 Perfluorovinyl ionic compounds and their use in conductive materials
10/27/2004	CN1539816A IL-8 receptor antagonist
10/27/2004	CN1172980C Stabilizers and antiozonants for elastomers
10/27/2004	CN1172909C Tetraene derivative and its production method
10/27/2004	CN1172665C Combined medicinal preparation of sodium/hydrogen exchange-pump inhibitor and medicine for treatment of angiocardiopathy
10/26/2004	US6809206 Contacting a phenyl ester compound with a cyclic compound in the presence of a source of cyanide or fluoride to prepare acylated cyclic 1,3-dicarbonyl compounds
10/21/2004	WO2004089885A1 Novel compounds
10/21/2004	WO2004089884A1 Novel compounds
10/21/2004	WO2004089883A1 Method for producing 3,3’-diallyl-4,4’-dihydroxydiphenylsulfone
10/21/2004	WO2004089876A1 Biphenylcarboxylic amide derivatives as p38 kinease inhibitors
10/21/2004	WO2004074350A3 Bicalutamide polymorphs
10/21/2004	US20040210051 Inhibitors of binding between vascular cell adhesion molecules and cells expressing vla-4 integrin; antiinflammatory agents
10/21/2004	US20040209949 Resorcinol derivatives
10/21/2004	DE10316318A1 Industrial-scale functionalizing of polyarylethersulfones for use in electrolytes, ion-exchangers, catalysts, polymer electrolyte membranes or blends involves halogenation, metallization and reaction with an electrophile
10/20/2004	EP1468987A1 Process for producing 2,4'-dihydroxydiphenyl sulfone
10/20/2004	EP1467968A1 N-(4-substituted phenyl)-anthranilic acid hydroxamate esters
10/20/2004	EP1467967A1 Compounds for modulating cell proliferation
10/20/2004	EP1467723A1 Phenyl sulfoxides and phenyl sulfones
10/20/2004	EP1282611B1 Substituted phenylacetamides and their use as glucokinase activators
10/20/2004	EP1282598B1 Method for producing sulfonyl-benzoyl guanidinium salts
10/20/2004	CN1171872C Compounds for modulation of PPAP gamma activity
10/20/2004	CN1171863C Carbamate derivatives and agricultural/horticulatrual bactericides
10/19/2004	US6806387 Process for preparation of allyl sulfone derivatives and intermediates for the preparation
10/19/2004	US6806365 N-alkanoylphenylalamine derivatives
10/14/2004	WO2004087644A1 Mercapto-phenyl-naphthyl-methane derivatives and preparation thereof
10/14/2004	WO2004000781A3 Nitrooxyderivatives of cyclooxygenase-2 inhibitors
10/14/2004	US20040204612 Process for preparation of carotenoids
10/14/2004	US20040204320 used as herbicides
10/13/2004	EP1466899A1 Hydroxamic acid derivative and mmp inhibitor containing the same as active ingredient
10/13/2004	EP1466898A1 Beta-amyloid protein production/secretion inhibitors
10/13/2004	EP1466897A1 Process for the preparation of organic compounds containing a sulfinyl or sulfonyl group in the presence of epsilon-phthalimidoperhexanoic acid
10/13/2004	EP1466891A1 Carboxylic acid derivative
10/13/2004	EP1466888A1 Calcium receptor-active arylalkyl amines
10/13/2004	EP1465863A1 Potassium channel modulators
10/13/2004	EP1465861A1 Alpha-(n-sulphonamido)acetamide derivatives as beta-amyloid inhibitors

1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 159